Donaldson Company

Donaldson to Webcast Fourth Quarter Fiscal 2023 Earnings Conference Call

Retrieved on: 
Thursday, August 3, 2023
Chemicals, Plastics, Other Energy, Technology, Other Technology, Manufacturing, Energy, Donaldson Company, DCI, NYSE

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, will webcast its fourth quarter 2023 earnings conference call on Tuesday, August 29, 2023, at 9:00 a.m. CT.

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, will webcast its fourth quarter 2023 earnings conference call on Tuesday, August 29, 2023, at 9:00 a.m. CT.
    To listen to a live webcast of the call, visit the “Events & Presentations” section of Donaldson’s Investor Relations website at IR.Donaldson.com and click on the “listen to webcast” option.
  • The webcast replay will be available within the “Events & Presentations” section of Donaldson’s Investor Relations website beginning at approximately 12:00 p.m. CT on Tuesday, August 29, 2023.

Donaldson Company Declares Quarterly Cash Dividend

Retrieved on: 
Friday, July 28, 2023
Other Energy, Utilities, Energy, Other Construction & Property, Food, Beverage, Other Manufacturing, Construction & Property, Other Transport, Retail, Engineering, Chemicals, Plastics, Transport, Manufacturing, Donaldson, Calendar, Donaldson Company, DCI, NYSE, Holding company

Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 25.0 cents per share.

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 25.0 cents per share.
  • The dividend is payable August 30, 2023, to shareholders of record on August 15, 2023.
  • Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index and calendar year 2022 marked the 27th consecutive year of annual dividend increases.
  • The Company has paid a cash dividend every quarter for 67 years.

Univercells Technologies Acquired by Donaldson Company

Retrieved on: 
Friday, June 30, 2023
Solaris, Vaccine, UT, Therapy, Donaldson Company, DCI, KKR, Sidley Austin, Donaldson, Rothschild & Co, Virus, NYSE, Pharmaceutical industry

MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that its operating company, Univercells Technologies ("UT"), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI).

Key Points: 
  • MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that its operating company, Univercells Technologies ("UT"), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI).
  • The deal follows several recent acquisitions by Donaldson in the field of bioprocessing, including Solaris Biotechnology, Purilogics and Isolere Bio.
  • According to the terms of the transaction, Donaldson acquired all outstanding shares of the business from Gamma and its fellow shareholder, Univercells SA, for approximately €136M in cash net of debt.
  • Sidley Austin LLP and Freshfields Bruckhaus Deringer US LLP acted as legal advisors to Gamma and Univercells, respectively.

Univercells Technologies Acquired by Donaldson Company

Retrieved on: 
Friday, June 30, 2023
Solaris, Vaccine, UT, Therapy, Donaldson Company, DCI, KKR, Sidley Austin, Donaldson, Rothschild & Co, Virus, NYSE, Pharmaceutical industry

MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that its operating company, Univercells Technologies ("UT"), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI).

Key Points: 
  • MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that its operating company, Univercells Technologies ("UT"), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI).
  • The deal follows several recent acquisitions by Donaldson in the field of bioprocessing, including Solaris Biotechnology, Purilogics and Isolere Bio.
  • According to the terms of the transaction, Donaldson acquired all outstanding shares of the business from Gamma and its fellow shareholder, Univercells SA, for approximately €136M in cash net of debt.
  • Sidley Austin LLP and Freshfields Bruckhaus Deringer US LLP acted as legal advisors to Gamma and Univercells, respectively.

Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach

Retrieved on: 
Thursday, June 29, 2023
Other Manufacturing, Machinery, HVAC, Machine Tools, Metalworking & Metallurgy, Engineering, Chemicals, Plastics, Automotive Manufacturing, Manufacturing, Therapy, COVID-19, Calendar, Donaldson Company, DCI, Research, Donaldson, NYSE, Acquisition, Virus, Risk management

“The acquisition of Univercells Technologies represents an important next step in Donaldson’s life sciences strategy, as we continue to expand our product portfolio aimed at providing customers with a comprehensive, differentiated offering,” said Tod Carpenter, chairman, president and chief executive officer of Donaldson.

Key Points: 
  • “The acquisition of Univercells Technologies represents an important next step in Donaldson’s life sciences strategy, as we continue to expand our product portfolio aimed at providing customers with a comprehensive, differentiated offering,” said Tod Carpenter, chairman, president and chief executive officer of Donaldson.
  • “Univercells Technologies’ engineered systems provide close adjacencies with our previous life sciences acquisitions as well as with our growing organic product suite.”
    “We are extremely excited to join Donaldson as we grow our portfolio of best-in-class biomanufacturing platforms and increase our market penetration and related installed base of equipment," said Mathias Garny, chief executive officer of Univercells Technologies.
  • “Our technology, complemented by Donaldson’s filtration excellence and existing life sciences capabilities is part of a larger vision to bring end-to-end solutions to market for advanced therapies.”
    Headquartered in Nivelles, Belgium, Univercells Technologies has over 100 employees globally.
  • Univercells Technologies is being acquired from Gamma Biosciences and Univercells SA and will be a part of the Donaldson Life Sciences segment.

Lindsay Corporation Reports Third Quarter Fiscal 2023 Results

Retrieved on: 
Thursday, June 29, 2023
Engineering, Manufacturing, Agriculture, Natural Resources, Other Manufacturing, Machinery, Zipper, Government, Internet, Growth, Food security, Lindsay Corporation, Donaldson Company, Video game

Infrastructure segment revenues for the third quarter of fiscal 2023 were $22.0 million, a decrease of $3.6 million, or 14 percent, compared to $25.6 million in the prior year third quarter.

Key Points: 
  • Infrastructure segment revenues for the third quarter of fiscal 2023 were $22.0 million, a decrease of $3.6 million, or 14 percent, compared to $25.6 million in the prior year third quarter.
  • Infrastructure segment operating income for the third quarter of fiscal 2023 was $3.6 million, a decrease of $0.2 million, or 6 percent, compared to the prior year third quarter.
  • Operating margin was 16.2 percent of sales, compared to 14.8 percent of sales in the prior year third quarter.
  • The timing of project execution at the state level can be difficult to predict and, because of delayed startups we have experienced to date, we expect a limited positive impact on our fiscal 2023 results and a more meaningful positive impact in fiscal 2024 and beyond.”
    Lindsay’s fiscal 2023 third quarter investor conference call is scheduled for 11:00 a.m. Eastern Time today.

Matt Fortuna Joins Rensa Filtration as President of Custom Filter

Retrieved on: 
Wednesday, June 28, 2023
Other Energy, HVAC, Manufacturing, Energy, Other Manufacturing, Machinery, Filtration, Growth, Donaldson Company, Engineering, Bottled water

Rensa Filtration, a manufacturer of consumable, mission-critical air filtration products, announced today that its Custom Filter subsidiary has named Matt Fortuna as its President.

Key Points: 
  • Rensa Filtration, a manufacturer of consumable, mission-critical air filtration products, announced today that its Custom Filter subsidiary has named Matt Fortuna as its President.
  • Matt Fortuna is joining from Lapp Tannehill, N.A., a distributor of wire and cable products, where he was most recently President and Managing Director.
  • “Matt is bringing decades of filtration and management experience to our business,” said Brandon Ost, CEO and Founder of Rensa Filtration.
  • We are planning for the continued growth of Custom Filter in the coming years both organically and through strategic acquisitions.”

Donaldson to Present at the William Blair 43rd Annual Growth Stock and Stifel 2023 Cross Sector Insight Conferences

Retrieved on: 
Monday, June 5, 2023
Other Manufacturing, Machinery, HVAC, Machine Tools, Metalworking & Metallurgy, Engineering, Chemicals, Plastics, Automotive Manufacturing, Manufacturing, Donaldson Company, DCI, NYSE, Conference

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced that Tod Carpenter, chairman, president, and chief executive officer will present at the William Blair 43rd Annual Growth Stock Conference on Wednesday, June 6, 2023, beginning at 4:00 p.m. CT. Mr. Carpenter will present at the Stifel 2023 Cross Sector Insight Conference on Thursday, June 7, 2023, beginning at 9:55 a.m. CT.

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced that Tod Carpenter, chairman, president, and chief executive officer will present at the William Blair 43rd Annual Growth Stock Conference on Wednesday, June 6, 2023, beginning at 4:00 p.m. CT. Mr. Carpenter will present at the Stifel 2023 Cross Sector Insight Conference on Thursday, June 7, 2023, beginning at 9:55 a.m. CT.
    To listen to a live webcast of the presentations, visit the “Events & Presentations” section of Donaldson’s Investor Relations website at IR.Donaldson.com and click on the “listen to webcast” option.
  • The webcast replays will be available within the “Events & Presentations” section of Donaldson’s Investor Relations website for approximately 90 days following the event.

Donaldson Company Announces Quarterly Cash Dividend Increase of 8.7%

Retrieved on: 
Wednesday, May 24, 2023
Other Manufacturing, Engineering, Chemicals, Plastics, HVAC, Automotive Manufacturing, Aerospace, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Donaldson, Calendar, Donaldson Company, DCI, NYSE, Holding company, Cryptocurrency

Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 25.0 cents per share, an increase of 8.7% from the prior quarterly dividend of 23.0 cents per share.

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 25.0 cents per share, an increase of 8.7% from the prior quarterly dividend of 23.0 cents per share.
  • The dividend is payable June 23, 2023, to shareholders of record on June 7, 2023.
  • Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index and calendar year 2022 marked the 27th consecutive year of annual dividend increases.
  • The Company has paid a cash dividend every quarter for 67 years.

Vuzix Reports Record Smart Glasses Sales in Q1 2023

Retrieved on: 
Wednesday, May 10, 2023
Software as a service, Outside, Smartglasses, Marketing, Research and development, Development, Administration, Engineering, LTIP, Growth, Vuzix, Cornerstone, OEM, Research, Donaldson Company, Cryptocurrency, Q2, M400

ROCHESTER, N.Y., May 10, 2023 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI) ("Vuzix" or the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products, today reported its first quarter results for the three months ended March 31, 2023.

Key Points: 
  • The increase in total revenues was due to higher product sales and specifically significantly higher unit sales of M400 smart glasses.
  • Research and Development expense was essentially flat at $3.1 million for the three months ended March 31, 2023 as compared to the prior year period.
  • As a result, we expect to achieve record overall revenues in 2023 fueled by stronger sales of core smart glasses, OEM products and engineering services, and SaaS solutions within our Moviynt subsidiary," said Mr. Travers.
  • "Although we are less than halfway through Q2, we are currently expecting another strong quarter that we expect will result in robust year-over-year growth in smart glasses products and solution sales in Q2.